| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.093 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |